ACF Investors’ Delta Fund led the round with participation from Mercia’s EIS fund. Simon Cartmell also led a solo investment.
Axis Spine Technologies will use the funds to launch devices in the U.S. and further develop its Oblique and Lateral cage implant systems.
The Axis-ALIF received FDA-clearance in May 2020, and the first surgery was completed with the devices in Atlanta in November 2020.
Note: Conversion from pound to USD was current as of Feb. 24.
More articles on surgery centers:
Amazon’s healthcare moves: 7 notes for ASCs and physicians
What ASC management company had the best 2020? & more — 9 ASC industry notes
3 joint-venture ASCs opened or announced in January
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.